Clinical Trials
7 trialsNCT03594630 2026-05-20
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT03943173 2026-02-25
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT07168785 2025-09-11
[18F]-AraG PET Imaging in LA HNSCC
Indiana University
Phase EARLY_PHASE1 Not yet recruiting
NCT06326736 2024-03-22
Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
Jinling Hospital, China
Phase EARLY_PHASE1 Recruiting
NCT02405078 2022-10-28
Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT01504126 2019-08-29
Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT03822130 2019-02-20
Intra-arterial Infusion Chemotherapy Combined With Sodium Bicarbonate for Unresectable Gastric Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase EARLY_PHASE1 Unknown